Navigation Links
Pradaxa Lawsuits Mount, as Claims in Federal Multidistrict Litigation Exceed 2,000, Bernstein Liebhard LLP Reports
Date:12/27/2013

New York, New York (PRWEB) December 27, 2013

Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to mount in the federal multidistrict litigation currently underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to court documents, at least 2,017 lawsuits had been filed in the litigation as of December 27, 2013. All of the complaints pending in the proceeding accuse Boehringer Ingelheim of failing to provide adequate warnings regarding the serious risk of Pradaxa bleeding, especially the lack of an effective antidote for such an event. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We hear from alleged victims of Pradaxa bleeding on a regular basis, so it is not surprising that the number of claims filed in this proceeding continues to climb. Our Firm expects that even more Pradaxa lawsuits will be filed in the coming year,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa lawsuit evaluations to individuals who suffered serious internal bleeding while using this medication.

Pradaxa Lawsuits
According to court documents, Pradaxa is a blood-thinning medication approved as a means of preventing strokes in people with atrial fibrillation. Upon its launch in 2010, Pradaxa was touted as a superior alternative to warfarin. However, lawsuits point out that while internal bleeding associated with decades-old warfarin can be stopped via the administration of vitamin k, there is no readily-available remedy for Pradaxa bleeding. Pradaxa lawsuits allege that due to the lack of an antidote, even a minor trauma can have serious health consequences for patients taking this medication.

In October, the Institute for Safe Medicine Practices (ISMP) reported that Pradaxa had been named in more than 3,200 adverse event reports made to the U.S. Food & Drug Administration (FDA) in 2012, including 582 fatalities. According to the ISMP analysis, Pradaxa led all other drugs in FDA adverse event reports that year. By contrast, warfarin was the subject of just 861 reports, including 56 deaths. *

The federal multidistrict litigation for Pradaxa lawsuits was established in August 2012. According to court documents, only 21 claims were transferred to the proceeding at that time. The litigation’s first bellwether trial is scheduled to begin in August 2014.

Alleged victims of Pradaxa bleeding may be entitled to compensation for medical bills, lost wages, pain and suffering, and other injury-related damages. To learn more about filing a Pradaxa lawsuit, please visit Bernstein Liebhard LLP’s website. For a free case review, please call 800-511-5092.

*ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP, October 17, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb11450192.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
2. Federal Judge Fines Boehringer Ingelheim More Than $931K Due To Missing Evidence in Pradaxa Lawsuits Disturbs Wright & Schulte LLC
3. Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes Judge’s Decision to Fine Boehringer Ingelheim for Failing to Preserve Documents Relevant to Pradaxa Bleeding Claims
4. As Pradaxa Lawsuits Move Forward, Bernstein Liebhard LLP Notes Manufacturer is Working on Possible Antidote for Internal Bleeding Caused by the Blood-Thinner
5. Pradaxa Lawsuit News: Wright & Schulte LLC Reports on Growing Pradaxa Bleeding Litigation, As Number of Filings Exceed 1,800
6. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on November Status Conference in Federal Pradaxa Bleeding Litigation
7. Pradaxa Bleeding Allegations Lawyer: Resource4thePeople Reports New Study May Produce Treatment to Reverse Anti-Clotting Medication Effects
8. Pradaxa Lawsuits Continue to Mount, With Filing of New Pradaxa Wrongful Death Claim in Pennsylvania by Wright & Schulte LLC
9. Pradaxa Lawsuits Progress, as Bernstein Liebhard LLP Notes Establishment of Bellwether Case Selection Protocol in Federal Pradaxa Bleeding Litigation
10. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
11. New Data on Pradaxa Bleeding Side Effects Draws Comment from Pradaxa Lawsuit Lawyers at Wright & Schulte LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... ... RANKED Health , a program to critically evaluate and rank health-focused applications ... the program is to provide independent, unbiased and accurate information to help accelerate ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... and CEO of EMED, today signed a multifaceted agreement which will allow for ... Northern Caribbean University Department of Natural and Applied Sciences, Allied Health and Nursing ...
(Date:4/30/2016)... ... , ... well is a challenge for all of us, but there are things we can do to ... “Research is showing more and more that there are simple, yet important steps that can ... age.” Top priorities Dr. Kohli’s recommends for her patients include;, , exercise ...
(Date:4/29/2016)... , ... April 30, 2016 , ... ... of patented products, announces the Pick Up Springboard, an automotive invention that improves ... Truck Manufacturing industry is worth $162 billion," says Scott Cooper, CEO and Creative ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published April 16th ... for Botox and lip injections, which she underwent in order to feel more at ... and Arts Festival. The article explains that Ms. Mirmelli’s situation is not unique; many ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
(Date:4/28/2016)... , April 28, 2016 ... development of innovative peptide and gene-based immunotherapeutics and vaccines for ... will be presenting at the 3rd Annual Growth Capital ... 5 th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 ... Sachs CEO Forums in Zürich gab Strekin ... führenden Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens ... wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie mit ... Frankreich angeworben. STR001 wird während der Operation ...
Breaking Medicine Technology: